FDA records linked by MedtechLedger identify Guangdong JINME Medical Technology Co., Ltd. as the applicant on K260275, a Traditional 510(k) for the Mobile Dental Solution (Models DS50, DS70, DS90). The record lists product code EIA, regulation 21 CFR 872.6640, device class 1, the Dental advisory committee, a receipt date of 2026-01-29 and a decision date of 2026-10-23 with decision code SESE, described as Substantially Equivalent. The filing carries a Summary and was not third-party reviewed. The applicant address on the record is in Foshan, Guangdong, China. [1][5]

Documented product identity and classification

The K260275 record names the device as Mobile Dental Solution with three model designations, DS50, DS70 and DS90. Its openFDA classification fields give the device name as Unit, Operative Dental, class 1, regulation number 872.6640 and medical specialty Dental, with product code EIA. The same classification details appear in the FDA.report entry for K260275, which also lists the review panel as Dental, clearance type Traditional and third-party review as N. [1][5]

The manufacturer’s own published site describes JINME Medical as founded in 2008 and based in Foshan, Guangdong, and states a commitment to research, development, production, sales and service. The site lists product families including the ES70/90 Surgical Drive System, the E8 Surgical Drive System, the J45 45° Minimally Invasive Extraction Handpiece, the E1 External Electric Motor Set, the EN1 unit and low-speed sets M1 and M2. These are company-published product names, not FDA determinations. [2][3]

Earlier FDA filings under the same applicant name

An FDA clearance letter dated November 13, 2024 addresses Guangdong JINME Medical Technology Co., Ltd. for submission K240337, with correspondence directed to a manager at Guangzhou GLOMED Biological Technology Co., Ltd. The letter’s device table lists Dental Handpiece, General Cutting Contra Handpiece, Dental High-speed Turbine Handpiece and Surgical Straight/Angle Handpiece, with prior 510(k) numbers K182999, K170229 and K171155 cited alongside K240337. [6]

A separate FDA substantial equivalence determination dated July 18, 2024 covers K240340 for the Surgical Drive System (Models ES70, ES90, E8) under 21 CFR 872.4120, Bone Cutting Instrument And Accessories, regulatory class II, again addressed to the same applicant through the Guangzhou correspondent. The model names overlap the ES70/90 and E8 product families listed on the manufacturer’s site. [7][3]

What the linked collection shows

The linked collection as retrieved on 2026-11-20 contains one 510(k) record, K260275, and its decision count is one SESE. The record sample contains that same single entry, so the sample decision count is also one SESE. These figures describe the linked filings at that retrieval time and are not measures of total company sales, total portfolio or safety performance. [1]

The manufacturer’s site states that 2024 brought the launch of IPO coaching and describes an aim to become China’s leading manufacturer of general dental equipment; it also lists four enterprise entities, 14 years of history in the oral industry, 50 core technologies and 168 dealers from 168 countries. Those figures are the publisher’s own statements and are not independently verified here. The site gives a Foshan address and contact details; the FDA filing address is a separate record field and is not treated as a headquarters determination. [2][3]

Brand documentation and stated design claims

The manufacturer’s download page offers a JINME Brand Manual dated 20251009 in English, a 1:5 Product Album and a 1:5 maintenance video. The page text states that the company ensures precise matching of gears and that dentists enjoy quiet, smooth and long-life performance; that is a manufacturer claim about its own products, not an FDA finding. [4]

The homepage presents the Dental Comprehensive Treatment Unit with implant function and the ES70/90 Surgical Drive System, and includes a statement that a component is 0.9 mm smaller than normal size, with each 0.01 mm improvement derived from thousands of experiments. These are published marketing statements attributed to JINME; no independent test data or clinical results are documented in the linked records. [3]